Phreesia saw a positive improvement to its Relative Strength (RS) Rating on Friday, rising from 86 to 91.
This exclusive rating from Investor's Business Daily measures market leadership with a 1 (worst) to 99 (best) score. The grade shows how a stock's price performance over the last 52 weeks compares to all the other stocks in our database.
Decades of market research shows that the stocks that go on to make the biggest gains often have an 80 or higher RS Rating as they begin their biggest price moves.
Here Are 3 Keys For Successful Stock Investing
While Phreesia is not near a proper buy zone right now, see if it goes on to form and break out of a proper consolidation.
The company showed 0% earnings growth in the latest quarterly report, while sales growth came in at 17%.
The company earns the No. 6 rank among its peers in the Computer Software-Medical industry group. Doximity, Waystar Holding and Veeva Systems Cl A are among the top 5 highly rated stocks within the group.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
